Argonaut Blog & News
New manufacturing strategies for the precision medicine future
Blockbuster drugs and one-size-fits-all treatments now share portfolio space with highly targeted therapies for smaller patient populations. This new era is an opportunity for savvy companies to create greater value, both for patients and themselves. [...]
How QSR-Compliant Medical Device Companies Can Switch to ISO 13485:2016
For decades, there has been a divide in the medical device regulatory landscape. While the U.S. Food and Drug Administration (FDA) has considered their Quality System Regulation (QSR) to be the minimum criteria for medical device manufacturing since [...]
Our top picks for BIO International 2019
The 2019 BIO International conference is only one week away! Here at Argonaut, our team is preparing for a week filled with partnership meetings and exciting talks. This year a major conference focus is on rare diseases and precision medicine. With t [...]
Selecting the Right CDMO Partner – Three Keys to Success
Outsourcing pharmaceutical manufacturing is becoming essential to remain competitive in the industry. The rise of small-batch personalized medicines and “virtual companies” are key drivers to retain flexible, external manufacturing capabilities. With [...]
Mission Bio Partners With LabCorp to Accelerate Targeted Drug Development with Single-Cell Genomics
Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials, along with the evaluation of potential applications in clinical diagnostics and companion diagnostics de [...]
Facility of the Future: Our takeaways from the ISPE Aseptic Conference 2019
The always-essential 2019 ISPE Aseptic Conference was held in North Bethesda, MD and we were there to assess the trends, check out the leading-edge sessions, and share lessons with industry leaders. Read on to find out what we found interesting or co [...]
How to Get Ahead in the NGS Service Lab Market
The sequencing service lab market is hot right now, with over 75,000 genetic tests already available and a predicted clinical sequencing market value of $7.7 billion by 2020. Rising maturity of analysis techniques coupled with decreasing sequencing c [...]
Does Your Contract Manufacturer’s Location Matter?
Location, location, location. Important for real estate, but does location matter when choosing a contract manufacturing partner? Absolutely. Breaking into an international market is challenging. A contract manufacturing organization (CMO) in your ta [...]
Preparing for an Economic Downturn in Biotech: Lessons from the Past
In 2008-2010, the economic downturn in biotech wreaked havoc on the unprepared industry. Fast forward a decade, and even though 2018 set a record in industry venture capital with over 700 deals and $17B funded, caution is in the air. Uncertainty exis [...]
Your Guide to Outsourcing Reagent & Assay Lyophilization
Upgrading your reagent or assay with lyophilization offers many advantages, but it can be difficult knowing how to start the process. At Argonaut we work with a wide range of clients, from the smallest startups to the largest biotechs. While these co [...]